(Q37166152)

18 August 2017

Psychopharmacology of topiramate: from epilepsy to bipolar disorder (English)

1 reference

18 August 2017

1 reference

Marco Mula

1

1 reference

18 August 2017

Andrea E Cavanna

series ordinal

2

1 reference

18 August 2017

Francesco Monaco

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Neuropsychiatric Disease and Treatment

18 August 2017

1 reference

18 August 2017

2

1 reference

18 August 2017

4

1 reference

18 August 2017

475-488

1 reference

Topiramate in the prevention of migraine: a review of its efficacy, tolerability, and acceptability

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Antiepileptic drugs: indications other than epilepsy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Newer anticonvulsants in the treatment of bipolar disorder.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Weight gain mitigation with topiramate in mood disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The diverse roles of anticonvulsants in bipolar disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Management of weight gain associated with antipsychotics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Safety of available agents used to treat bipolar disorder: focus on weight gain

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Antidepressant properties of anticonvulsant drugs for bipolar disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Combining lithium and anticonvulsants in bipolar disorder: a review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Relevance of new and newly rediscovered anticonvulsants for atypical forms of bipolar disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Review of the use of topiramate for treatment of bipolar disorders

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The use of topiramate in mood stabilization

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The nature of bipolar disorder.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Open-label adjunctive topiramate in the treatment of bipolar disorders.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The psychopharmacologic specificity of the lithium ion: origins and trajectory.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Factors associated with behavioral and cognitive abnormalities in children receiving topiramate.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Antipsychotic-induced weight gain: a comprehensive research synthesis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

GABA and glutamate transporters: therapeutic and etiologic implications for epilepsy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Novel antipsychotics: comparison of weight gain liabilities.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Mood stabilizer combinations: a review of safety and efficacy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

GABA receptor agonists: pharmacological spectrum and therapeutic actions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Calcium channel blockers in affective illness: role of sodium-calcium exchange.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Treatment of mood disorders with antiepileptic medications: clinical and theoretical implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Long term treatment of bipolar disorder

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Predictors of response to mood stabilizers

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Outcome in the pharmacologic treatment of bipolar disorder

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

GABA and mood disorders: a brief review and hypothesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The place of anticonvulsant therapy in bipolar illness

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Use of topiramate in treatment-resistant bipolar spectrum disorders.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate induced manic episode

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A pilot study of topiramate as monotherapy in the treatment of acute mania

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Use of topiramate, a new anti-epileptic as a mood stabilizer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate increases cerebral GABA in healthy humans.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

An audit of topiramate use in a general neurology clinic.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Beyond lithium in the treatment of bipolar illness.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate: a new antiepileptic drug

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A pharmacological and clinical review on topiramate, a new antiepileptic drug

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Novel alternatives and supplements to lithium and anticonvulsants for bipolar affective disorder

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Vigabatrin and behaviour disorders: a retrospective survey.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Safety of topiramate: adverse events and relationships to dosing

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Low plasma GABA is a trait-like marker for bipolar illness

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate and divalproex in combination with risperidone for acute mania: a randomized open-label study

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate and psychiatric adverse events in patients with epilepsy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate: efficacy and tolerability in children according to epilepsy syndromes.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate and word-finding difficulties in patients with epilepsy

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Treatment of acute mania with topiramate in hospitalized patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Hippocampal changes in patients with a first episode of major depression.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Postmarketing experience with topiramate and cognition

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate-induced depression

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

First break of mania associated with topiramate treatment

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Antimanic efficacy of topiramate in 11 patients in an open trial with an on-off-on design

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Effectiveness and safety of topiramate in treatment-resistant bipolar disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Hippocampal volume reduction in major depression.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Olanzapine increases weight and serum triglyceride levels.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Weight gain associated with antipsychotic drugs.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Mood stabilization and weight loss with topiramate

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

The efficacy and use of anticonvulsants in mood disorders.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Depression during mania. Treatment response to lithium or divalproex.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Relapse and impairment in bipolar disorder

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2671954

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

3 September 2018

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Topiramate as add-on treatment for patients with bipolar mania

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Course and outcome in bipolar affective disorder: a longitudinal follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Antimanic Efficacy of Topiramate in 11 Patients in an Open Trial With an On-Off-On Design

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Tiagabine: The Safety Landscape

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Sudden unexpected death in epilepsy: impact on clinical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Outcome of bipolar disorder on long-term treatment with lithium

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Association between premenstrual syndrome and depression

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Topiramate: a potent anticonvulsant in the amygdala-kindled rat

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Antiepileptic drugs in pediatric practice

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Mental Health Service Utilization by Borderline Personality Disorder Patients and Axis II Comparison Subjects Followed Prospectively for 6 Years

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate

31 March 2020

1 reference

https://api.crossref.org/works/10.2147%2FNEDT.2006.2.4.475

Effects of topiramate on sodium-dependent action-potential firing by mouse spinal cord neurons in cell culture

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19412496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Topiramate as an inhibitor of carbonic anhydrase isoenzymes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19412496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19412496

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2147/NEDT.2006.2.4.475

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19412496

1 reference